We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFIB
3776
DELISTED
Acutus Medical Inc
AFIB
$23K ﹤0.01%
1,370
-2,132
-61% -$31.2K
ZEV
3777
DELISTED
Lightning eMotors, Inc.
ZEV
$23K ﹤0.01%
140
-232
-62% -$39.6K
AUD
3778
DELISTED
Audacy, Inc.
AUD
$23K ﹤0.01%
5,364
-29,473
-85% -$135K
BNFT
3779
DELISTED
Benefitfocus, Inc.
BNFT
$23K ﹤0.01%
1,627
-3,484
-68% -$49.1K
IGAC
3780
DELISTED
IG Acquisition Corp. Class A Common Stock
IGAC
$23K ﹤0.01%
+2,371
New +$23.3K
OYST
3781
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$23K ﹤0.01%
1,311
+352
+37% +$6.69K
WMC
3782
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$23K ﹤0.01%
727
-372
-34% -$12.3K
ATH
3783
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$23K ﹤0.01%
339
-15,671
-98% -$943K
MSGN
3784
DELISTED
MSG Networks Inc.
MSGN
$23K ﹤0.01%
1,551
-7,024
-82% -$109K
ORBC
3785
DELISTED
ORBCOMM, Inc.
ORBC
$23K ﹤0.01%
2,073
-12,306
-86% -$136K
ACNT icon
3786
Ascent Industries
ACNT
$138M
$22K ﹤0.01%
2,209
+1,453
+192% +$14.4K
AROC icon
3787
Archrock
AROC
$5.78B
$22K ﹤0.01%
2,543
-8,766
-78% -$81.8K
ATNI icon
3788
ATN International
ATNI
$481M
$22K ﹤0.01%
493
+38
+8% +$1.81K
ATRO icon
3789
Astronics
ATRO
$3.7B
$22K ﹤0.01%
1,508
-1,978
-57% -$28.7K
BZQ icon
3790
ProShares UltraShort MSCI Brazil Capped
BZQ
$2.7M
$22K ﹤0.01%
+229
New +$26.9K
CLDT
3791
Chatham Lodging
CLDT
$580M
$22K ﹤0.01%
1,757
-4,549
-72% -$60.7K
COE
3792
51Talk Online Education Group
COE
$120M
$22K ﹤0.01%
+691
New +$42.8K
DK icon
3793
Delek US
DK
$3.92B
$22K ﹤0.01%
1,009
-7,137
-88% -$161K
DMAC icon
3794
DiaMedica Therapeutics
DMAC
$370M
$22K ﹤0.01%
4,949
+4,039
+444% +$33.1K
EBF icon
3795
Ennis
EBF
$560M
$22K ﹤0.01%
1,003
-4,529
-82% -$95.7K
EEX
3796
DELISTED
Emerald Holding
EEX
$22K ﹤0.01%
3,991
-328
-8% -$1.76K
EQBK icon
3797
Equity Bancshares
EQBK
$1.06B
$22K ﹤0.01%
705
-790
-53% -$24.2K
FTDR icon
3798
Frontdoor
FTDR
$5.76B
$22K ﹤0.01%
444
-5,714
-93% -$301K
GEF.B icon
3799
Greif Class B
GEF.B
$4.23B
$22K ﹤0.01%
368
-701
-66% -$42.2K
GPRE icon
3800
Green Plains
GPRE
$1.09B
$22K ﹤0.01%
655
-4,163
-86% -$124K

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.